Philips Oy
✅ Low Risk
FEI: 3002807913 • Vantaa, Helsinki-Uusimaa • FINLAND
FEI Number
3002807913
Location
Vantaa, Helsinki-Uusimaa
Country
FINLANDAddress
Ayritie 4, , Vantaa, Helsinki-Uusimaa, Finland
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/24/2014 | 73CAFNEBULIZER (DIRECT PATIENT INTERFACE) | 341REGISTERED | Division of Northern Border Imports (DNBI) |
Frequently Asked Questions
What is Philips Oy's FDA import refusal history?
Philips Oy (FEI: 3002807913) has 1 FDA import refusal record(s) in our database, spanning from 12/24/2014 to 12/24/2014.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Philips Oy's FEI number is 3002807913.
What types of violations has Philips Oy received?
Philips Oy has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Philips Oy come from?
All FDA import refusal data for Philips Oy is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.